Cannabis policy and consolidation lead today’s news, with Curaleaf advancing its contested bid for Aurora Cannabis and federal regulators beginning to define the production framework surrounding rescheduling. In Los Angeles, a rush-hour crash outside a major transit station has left three people dead and prompted a detailed police investigation.
Curaleaf Clears Competition Reviews for Aurora Cannabis Bid
Curaleaf Holdings said it has received all required competition-law clearances for its proposed acquisition of Aurora Cannabis. Canada’s Competition Bureau issued a no-action letter, while German authorities approved the proposed transfer of Aurora’s European operations and confirmed that the transaction could proceed under German competition law. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1756770/000162828026072648/a2026-11x10xcuraleafxrec.htm))
Curaleaf’s enhanced offer remains open until December 4 unless it is withdrawn or amended. Aurora, meanwhile, has entered a board-backed agreement to be acquired by Organigram Global, leaving shareholders to evaluate two competing paths. Curaleaf’s bid still has other conditions that must be satisfied or waived. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1756770/000162828026072647/a2026-11x10xcuraleafxrec.htm?utm_source=openai))
Why It Matters: Analysis: Removing the competition-law hurdle gives Curaleaf additional leverage in one of the cannabis industry’s most consequential takeover battles. The outcome could reshape ownership of major Canadian and European medical cannabis assets while establishing new benchmarks for consolidation across the sector.
Source: Curaleaf Holdings / U.S. Securities and Exchange Commission
DEA Prepares Separate Production Limits for Schedule III Marijuana
The Drug Enforcement Administration proposed authorizing 6.675 million grams of Schedule I marijuana and 1 million grams of marijuana extract for federally permitted production in 2027, maintaining the existing marijuana limits. The quotas apply to federally authorized activities such as research and manufacturing rather than state-regulated commercial markets. ([govinfo.gov](https://www.govinfo.gov/content/pkg/FR-2026-11-10/pdf/FR-2026-11-10.pdf?utm_source=openai))
The notice also says the DEA intends to propose separate quotas for marijuana products classified under Schedule III. Public comments on the current proposal are due December 10, after which the agency can issue its final production order. ([govinfo.gov](https://www.govinfo.gov/content/pkg/FR-2026-11-10/pdf/FR-2026-11-10.pdf?utm_source=openai))
Why It Matters: Analysis: The forthcoming Schedule III quotas will be an important part of the federal operating framework for registered medical cannabis manufacturers and distributors. Their size and structure could influence who can participate in the federally recognized supply chain and how quickly production can expand.
Source: Federal Register
Three Killed in Crash Outside North Hollywood Metro Station
A minivan crashed into pedestrians and street vendors outside the North Hollywood Metro station shortly before 6 p.m. Tuesday, killing three people. The driver and at least two other people were critically injured, according to authorities. ([apnews.com](https://apnews.com/article/los-angeles-car-into-pedestrians-6b8fc32f9fea3956e42b77f5d98f0825))
Los Angeles police said investigators had not determined whether the crash was intentional or accidental and planned to conduct a frame-by-frame review of available video. One station entrance remained closed Tuesday night, but Metro’s bus and subway services continued operating. ([apnews.com](https://apnews.com/article/los-angeles-car-into-pedestrians-6b8fc32f9fea3956e42b77f5d98f0825))
Why It Matters: The collision occurred at one of the San Fernando Valley’s busiest transit hubs and affected pedestrians and vendors operating around the station. The investigation could bring renewed scrutiny to vehicle access, sidewalk protections and public-safety design around high-traffic Los Angeles transit corridors.
Source: Associated Press
What We’re Watching
Over the next 24 to 72 hours, watch for any response from Aurora or Organigram to Curaleaf’s regulatory clearances, additional details about the DEA’s forthcoming Schedule III production proposal, and updates from Los Angeles investigators on the cause of the North Hollywood crash.
